Nucleocapsid protein of SARS-CoV activates the expression of cyclooxygenase-2 by binding directly to regulatory elements for nuclear factor-kappa B and CCAAT/enhancer binding protein-Reference-Cited by-同舟云学术

Nucleocapsid protein of SARS-CoV activates the expression of cyclooxygenase-2 by binding directly to regulatory elements for nuclear factor-kappa B and CCAAT/enhancer binding protein

Published:2006-01 Issue:8 Volume:38 Page:1417-1428
ISSN:1357-2725
Container-title:The International Journal of Biochemistry & Cell Biology
language:en
Short-container-title:The International Journal of Biochemistry & Cell Biology

Author:

Yan Xiaohong,Hao Qian,Mu Yongxin,Timani Khalid Amine,Ye Linbai,Zhu Ying,Wu Jianguo

Publisher

Elsevier BV

Subject

Cell Biology,Biochemistry

Reference27 articles.

1. HIV-1 gp120-induced apoptosis in the rat neocortex involves enhanced expression of cyclooxygeanse type2 (COX-2);Bagetta;Biochem. Biophys. Res. Commun.,1998

2. Analysis of multimerization of the SARS coronavirus nucleocapsid protein;He;Biochem. Biophys. Res. Commun.,2004

3. Activation of AP-1 signal transduction pathway by SARS coronavirus nucleocapsid protein;He;Biochem. Biophys. Res. Commun.,2003

4. Transcriptional regulation of cyclooxygenase-2 in mouse skin carcinoma cells;Kin;J. Biol. Chem.,1998

5. A novel coronavirus associated with severe acute respiratory syndrome;Ksiazek;N. Engl. J. Med.,2003

Cited by 122 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Indomethacin inhibits human seasonal coronaviruses at late stages of viral replication in lung cells: effect on virus-induced COX-2 expression;Journal of Virus Eradication;2024-09

2. Illuminating the pathogenic role of SARS-CoV-2: Insights into competing endogenous RNAs (ceRNAs) regulatory networks;Infection, Genetics and Evolution;2024-08

3. Nucleotide metabolism-related host proteins RNA polymerase II subunit and uridine phosphorylase 1 interacting with porcine epidemic diarrhea virus N proteins affect viral replication;Frontiers in Veterinary Science;2024-06-12

4. Evaluating NSAIDs in SARS-CoV-2: Immunomodulatory mechanisms and future therapeutic strategies;Heliyon;2024-02

5. Over-representation analysis of angiogenic factors in immunosuppressive mechanisms in neoplasms and neurological conditions during COVID-19;Microbial Pathogenesis;2023-12